Q. I have a calcified aorta that my doctor says supplies blood to my feet. How does this happen? –N.K., Flushing, N.Y. A. The calcium in your aorta is probably the result of atherosclerosis. This ...

In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to alter ...

Aortic stenosis happens when your aortic valve does not open all the way causing pressure to build in the left ventricle. This pressure blocks blood flow as it leaves the heart. In other words, the ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

Calcific aortic stenosis in the elderly is the number one cause of surgical valve replacement in the US and Europe. The incidence of calcific aortic stenosis is increasing as the general age of the ...

Aortic stenosis is a disease of the heart valve. It involves the narrowing of the aortic heart valve, which reduces blood flow. The condition may cause a person to feel fatigued due to restricted ...

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Oral calcium supplementation was associated with lower survival and a greater need for aortic valve replacement in elderly patients with mild to moderate aortic stenosis, a new study finds. "Our ...

Dementia characterises a set of symptoms linked to the progressive degeneration of cognitive functions. Research into the disease has brought incalculable improvements to the lives of sufferers, but ...

PARIS -- A device that slices calcium bridges on valves affected by calcified aortic stenosis helped leaflet mobility in patients slated for transcatheter aortic valve replacement (TAVR), researchers ...

The Phase 2, randomized, double-blind clinical trial included 23 patients randomized to either 200 mg ataciguat (n=12) or placebo (n=11) once daily for a 12-month period. The primary Phase 2 clinical ...